The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
The microbiome and cancer
Open accessAbstract
Microbiota and host form a complex 'super-organism' in which symbiotic relationships confer benefits to the host in many key aspects of life. However, defects in the regulatory circuits of the host that control bacterial sensing and homeostasis, or alterations of the microbiome, through environmental changes (infection, diet or lifestyle), may disturb this symbiotic relationship and promote disease. Increasing evidence indicates a key role for the bacterial microbiota in carcinogenesis. In this Opinion article, we discuss links between the bacterial microbiota and cancer, with a particular focus on immune responses, dysbiosis, genotoxicity, metabolism and strategies to target the microbiome for cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The microbial microenvironment is primarily comprised of intestinal and intra-tumoral microorganisms and their metabolites, which possess the ability to either facilitate or inhibit tumor progression and impact the effectiveness and toxicity of cancer treatments.329–332”
From Drug repurposing for cancer therapy (2024) · cites this paper as [332]
Experimental — accuracy not yet measuredIn the citing paper
“Exposure to broad-spectrum antibiotic (ATB) therapy may adversely influence outcomes of ICI therapy 2 through modulation of intestinal microbiota, 3 a key host determinant of response to ICIs known to precondition cancer-specific immunity.4”
From Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer (2019) · cites this paper as [4]
In the citing paper
“In particular, the regulation of such therapeutic outcome is tightly connected with the ability of the gut microbiota to metabolize anti-tumoral compounds, as well as to modulate host’s immune response and inflammation pathways [164].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Flagged first, then by citations
Research works printed but not linked: 2
- Koch, R. in Tenth International Congress of Medicine 1 (August Hirschwald, Berlin, 1891).
- Laqueur, G. L., Matsumoto, H. & Yamamoto, R. S. Comparison of the carcinogenicity of methylazoxymethanol-β-D-glucosiduronic acid in conventional and germfree Sprague-Dawley rats. J. Natl Cancer Inst. 67, 1053–1055 (1981).
Cited by
Sorted by citations
Items 801–900 of 1,001
Nutrition in cancer patients with cachexia: A role for the gut microbiota?
Bindels, L. B., & Thissen, J.-P. (2015) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2015.11.001 · Cited by 25
HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases
Herrera, S., Martínez‐Sanz, J., & Villar, S. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01466 · Cited by 25
Korneev, K. V., Sviriaeva, E. N., Mitkin, N. A., Gorbacheva, A. M., Uvarova, A. N., Ustiugova, A. S., Polanovsky, O. L., Kulakovskiy, I. V., Afanasyeva, M. A., Schwartz, A. M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165626 · Cited by 25
Cancer and the Microbiome of the Human Body
Herrera‐Quintana, L., Vázquez‐Lorente, H., López-Garzón, M., Cortés‐Martín, A., & Plaza‐Díaz, J. (2024) · Nutrients · doi:10.3390/nu16162790 · Cited by 25
Ambrosio, M. R., Vernillo, R., Carolis, S. D., Carducci, A., Mundo, L., Ginori, A., Rocca, B. J., Nardone, V., Fei, A. L., Carfagno, T., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00093 · Cited by 24
Castillo, P. A., Nonnecke, E. B., Ossorio, D. T., Tran, M. T. N., Goley, S. M., Lönnerdal, B. L., Underwood, M. A., & Bevins, C. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-49471-9 · Cited by 26
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects
Pilla, L., Alberti, A., di Mauro, P., Gemelli, M. T., Cogliati, V., Cazzaniga, M. E., Bidoli, P., & Maccalli, C. (2020) · Cancers · doi:10.3390/cancers12113456 · Cited by 24
Impact of Appendectomy on Gut Microbiota
Бабаханов, А. Т., ДЖУМАБЕКОВ, А. Т., Zhao, A., Kuandykov, Y., Tanabayeva, S. B., Fakhradiyev, I. R., Nazarenko, Y., & Saliev, T. M. (2021) · Surgical Infections · doi:10.1089/sur.2020.422 · Cited by 26
Gupta, I., Pedersen, S., Vranić, S., & Moustafa, A. A. (2022) · Cancers · doi:10.3390/cancers14122964 · Cited by 25
microbioTA: an atlas of the microbiome in multiple disease tissues of Homo sapiens and Mus musculus
Wang, P., Zhang, S., He, G., Du, M., Qi, C., Liu, R., Zhang, S., Cheng, L., Shi, L., & Zhang, X. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac851 · Cited by 24
Intratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 26
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
Mendes, I., & Vale, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411855 · Cited by 24
Opportunities for Cancer Prevention During Midlife
Holman, D. M., Grossman, M., Henley, S. J., Peipins, L. A., Tison, L. I., & White, M. C. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.030 · Cited by 24
CpG Oligodeoxynucleotides as Adjuvants for Clinical Use
Shirota, H., & Klinman, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804019-5.00009-8 · Cited by 24
Chen, Y., Yang, Y., & Gu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s240108 · Cited by 24
Kulecka, M., Czarnowski, P., Bałabas, A., Turkot, M. H., Kruczkowska‐Tarantowicz, K., Żeber‐Lubecka, N., Dąbrowska, M., Paszkiewicz‐Kozik, E., Walewski, J. A., Lugowska, I. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158026 · Cited by 24
Silva, S. D., Tennekoon, K. H., & Karunanayake, E. H. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s329383 · Cited by 23
The effect of probiotics supplementation in postoperative cancer patients: a prospective pilot study
Kwon, H., Chae, S. H., Jung, H. J., Shin, H., Ban, O., Yang, J., Kim, J. H., Jeong, J. E., Jeon, H. M., Kang, Y. W., et al. (2021) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2021.101.5.281 · Cited by 23
Lipopolysaccharide-Induced Immunological Tolerance in Monocyte-Derived Dendritic Cells
Mbongue, J. C., Vanterpool, E., Firek, A. F., & Langridge, W. H. R. (2022) · Immuno · doi:10.3390/immuno2030030 · Cited by 26
Islam, M. Z., Tran, M. A., Xu, T., Tierney, B. T., Patel, C. J., & Kostic, A. D. (2022) · Microbiome · doi:10.1186/s40168-022-01373-1 · Cited by 23
The human microbiome: A promising target for lung cancer treatment
Sun, Y. H., Wen, M., Liu, Y., Wang, Y., Jing, P., Gu, Z., Jiang, T., & Wang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091165 · Cited by 24
Therapeutic and immunomodulatory role of probiotics in breast cancer: A mechanistic review
Summer, M., Ali, S., Fiaz, U., Tahir, H. M., Ijaz, M. U., Mumtaz, S., Mushtaq, R., Khan, R., Shahzad, H., & Fiaz, H. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03632-7 · Cited by 23
Geistlinger, L., Mirzayi, C. A., Zohra, F., Azhar, R., Elsafoury, S., Grieve, C., Wokaty, J., Gamboa-Tuz, S. D., Sengupta, P., Hecht, I., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01872-y · Cited by 23
A graph neural network approach for predicting drug susceptibility in the human microbiome
Maryam, M., Rehman, M. U., Hussain, I., Tayara, H., & Chong, K. T. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108729 · Cited by 24
Chaiyasut, C., Pattananandecha, T., Sirilun, S., Suwannalert, P., Peerajan, S., & Sivamaruthi, B. S. (2016) · Food Science and Technology · doi:10.1590/1678-457x.26216 · Cited by 23
Microbial carcinogenic toxins and dietary anti-cancer protectants
Stone, T. W., & Darlington, L. G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2487-z · Cited by 23
Can intestinal microbiota be associated with non-intestinal cancers?
Jacqueline, C. M., Brazier, L., Faugère, D., Renaud, F., Frédéric Thomas, A., & Roche, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-11644-9 · Cited by 23
Thomsen, M., Clarke, S. J., & Vitetta, L. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0172 · Cited by 23
Wang, H., Yan, Y., Yi, X., Duan, Y., Wang, J., Li, S., Luo, L., Huang, T., Inglis, B. M., Li, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00165 · Cited by 23
Jiang, X., Liu, S., Zhang, Y., Ji, Y., Sohail, A., Cao, C., Wang, P., & Xiao, H. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02627 · Cited by 23
Spot-light on microbiota in obesity and cancer
Marzullo, P., Bettini, S., Menafra, D., Aprano, S., Muscogiuri, G., Barrea, L., Savastano, S., Colao, A., Colao, A., Savastano, S., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00866-7 · Cited by 23
Emerging Complexity in CD4+T Lineage Programming and Its Implications in Colorectal Cancer
Ditoro, D. F., & Basu, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694833 · Cited by 23
Remodelling of colorectal cancer cell signalling by microbiota and immunity in diabetes
Gutiérrez‐Salmerón, M. T., Lucena, S. R., Chocarro‐Calvo, A., García-Martínez, J. M., Orozco, R. M. M., & García‐Jiménez, C. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0315 · Cited by 22
The Role of Microbial Factors in Prostate Cancer Development—An Up-to-Date Review
Garbas, K., Zapała, P., Zapała, Ł., & Radziszewski, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204772 · Cited by 22
Genton, L., Lazarević, V., Stojanović, O., Spiljar, M., Djaafar, S., Koessler, T., Dutoit, V., Gaïa, N., Mareschal, J., Macpherson, A. J., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.752889 · Cited by 25
Trifanescu, O. G., Trifanescu, R. A., Mitrica, R. I., Bran, D. M., Serbanescu, L. G., Valcauan, L., Marinescu, Ș. A., Gales, L. N., Tănase, B. C., & Anghel, R. M. (2023) · Diagnostics · doi:10.3390/diagnostics13050877 · Cited by 25
Early-Onset GI Cancers: Rising Trends, Genetic Risks, Novel Strategies, and Special Considerations
Harrold, E., Latham, A. J., Pemmaraju, N., & Lieu, C. H. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_398068 · Cited by 22
Qin, W., Wang, S., Min, Y., Liu, X., Fang, J., Lang, J., & Chen, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03599-1 · Cited by 23
Heinrich, A., Haarmann, H., Zahradnik, S., Frenzel, K., Schreiber, F., Klassert, T. E., Heyl, K. A., Endres, A., Schmidtke, M., Hofmann, J., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500172r · Cited by 23
Gnotobiotic mouse model’s contribution to understanding host–pathogen interactions
Kubelková, K., Benuchova, M., Kozáková, H., Šinkora, M., Kročová, Z., Pejchal, J., & Macela, A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2341-8 · Cited by 22
Omics for Understanding the Gut‐Liver‐Microbiome Axis and Precision Medicine
Khalsa, J. H., Duffy, L. C., Riscuta, G., Starke-Reed, P. E., & Hubbard, V. S. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.310 · Cited by 22
Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group
Marcotte, E. L., Richardson, M. R., Roesler, M. A., & Spector, L. G. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0778 · Cited by 22
Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
Li, J., Li, J., Lyu, N., Ma, Y., Liu, F., Feng, Y., Li, Y., Hou, Z., Song, X., Zhao, H.-C., et al. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320904293 · Cited by 23
The Composition Alteration of Respiratory Microbiota in Lung Cancer
Zheng, X. E., Sun, X., Liu, Q., Huang, Y., & Yuan, Y. (2020) · Cancer Investigation · doi:10.1080/07357907.2020.1732405 · Cited by 23
Hsueh, C., Gong, H., Cong, N., Sun, J., Lau, H., Guo, Y., Huang, Q., Yuan, X., Zhang, M., Tao, L., et al. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.01849-20 · Cited by 22
Sholl, J., Mailing, L. J., & Wood, T. R. (2021) · mBio · doi:10.1128/mbio.00579-21 · Cited by 23
Chen, H., Wang, B., Zhao, R., Gao, D., Guan, M., Zheng, L., Zhou, X., Chai, Z., Zhao, Y., & Feng, W. (2015) · Small · doi:10.1002/smll.201500136 · Cited by 21
Effect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells
Xu, Y., Jia, Y., Chen, L., Gao, J., & Yang, D. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01505-3 · Cited by 21
Borchmann, S. (2021) · Microbiome · doi:10.1186/s40168-021-01039-4 · Cited by 21
DiMaio, D., Emu, B., Goodman, A. L., Mothes, W., & Justice, A. C. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab212 · Cited by 21
In situ imaging for tumor microbiome interactions via imaging mass cytometry on single‐cell level
Feng, Z., Hu, Y., Wang, X., Li, Y., Yu, Y., He, J., Li, H., Zhang, T., Zhang, L., Shen, G., et al. (2022) · Cytometry Part A · doi:10.1002/cyto.a.24550 · Cited by 21
The Microbiome’s Influence on Head and Neck Cancers
Dorobisz, K., Dorobisz, T. A., & Zatoński, T. (2023) · Current Oncology Reports · doi:10.1007/s11912-022-01352-7 · Cited by 21
Peng, L., Huang, L., Tian, G., Wu, Y., Li, G., Cao, J., Wang, P., Li, Z., & Duan, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244527 · Cited by 21
Microbiote intestinal et réponses aux thérapies anti-tumorales
Vétizou, M., Daillère, R., & Zitvogel, L. (2016) · médecine/sciences · doi:10.1051/medsci/20163211013 · Cited by 21
Human Intestinal Microbiota and Colorectal Cancer: Moving Beyond Associative Studies
Jobin, C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.030 · Cited by 21
Self-citationDanese, E., Ruzzenente, A., Montagnana, M., & Lievens, P. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.16 · Cited by 22
Liu, A.-Q., Vogtmann, E., Shao, D., Abnet, C. C., Dou, H.-Y., Yu, Q., Su, Z., Wei, W., & Chen, W. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1210 · Cited by 21
Moynihan, M. J., Sullivan, T., Provenzano, K., & Rieger‐Christ, K. (2019) · Research and Reports in Urology · doi:10.2147/rru.s233386 · Cited by 21
An ambient temperature collection and stabilization strategy for canine microbiota studies
Lin, C.-Y., Cross, T.-W., Doukhanine, E., & Swanson, K. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-70232-6 · Cited by 22
Cheema, A. K., Maier, I., Dowdy, T., Wang, Y., Singh, R., Ruegger, P. M., Borneman, J., Fornace, A. J., & Schiestl, R. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151190 · Cited by 22
Methodological Strategies in Microbiome Research and their Explanatory Implications
O’Malley, M. A., & Skillings, D. (2018) · Perspectives on Science · doi:10.1162/posc_a_00274 · Cited by 22
Liu, Y., Weyrich, L. S., & Llamas, B. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz231 · Cited by 21
Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome
Tanaka, Y., Shimizu, S., Shirotani, M., Yorozu, K., Kitamura, K., Oehorumu, M., Kawai, Y., & Fukuzawa, Y. (2021) · Nutrients · doi:10.3390/nu13103326 · Cited by 20
The Role of Gut Microbiota in Gastrointestinal Tract Cancers
Grochowska, M., Perlejewski, K., Laskus, T., & Radkowski, M. (2022) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-021-00641-6 · Cited by 20
Linkens, A. M. A., van Best, N., Niessen, P., Wijckmans, N. E. G., de Goei, E. E. C., Scheijen, J. L. J. M., DONGEN, M. C. J. M. V., van Gool, C. J., de Vos, W. M., Houben, A. J. H. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105328 · Cited by 20
Ganly, I., Hao, Y., Rosenthal, M. H., Wang, H., Migliacci, J. C., Huang, B., Katabi, N., Brown, S. M., Tang, Y., Pei, Z., et al. (2022) · Cancers · doi:10.3390/cancers14246096 · Cited by 20
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory
Artusa, V., Calabrone, L., Mortara, L., Peri, F., & Bruno, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054997 · Cited by 22
The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status
Vargas-Robles, D., Romaguera, J., Alvarado-Vélez, I., Tosado-Rodríguez, E. L., Dominicci-Maura, A., Sánchez, M. M., Wiggin, K. J., Gilbert, J. A., Martínez‐Ferrer, M., Forney, L. J., et al. (2023) · mSystems · doi:10.1128/msystems.00357-23 · Cited by 20
Burkett, W. C., Clontz, A. D., Keku, T. O., & Bae-Jump, V. L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189000 · Cited by 23
The microbiome: a link between obesity and breast cancer risk
Gaber, M. K., Arnone, A. A., Vidi, P., & Cook, K. L. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1394719 · Cited by 21
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
Haedenkamp, T. M., Leitzmann, M. F., Linker, R. A., Meier, C. R., Becker, C., Jick, S. S., Sahm, K., Platten, M., Hau, P., & Seliger, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2767 · Cited by 20
Park, Y., Lee, J., Moon, H., Choi, Y. S., & Rho, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83966-8 · Cited by 20
Characterization of the consensus mucosal microbiome of colorectal cancer
Zhao, L., Grimes, S. M., Greer, S., Kubit, M. A., Lee, H., Nadauld, L. D., & Ji, H. P. (2021) · NAR Cancer · doi:10.1093/narcan/zcab049 · Cited by 20
Robinson, K. M., & Hotopp, J. C. D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.021 · Cited by 20
Agaro-oligosaccharides: a new frontier in the fight against colon cancer?
Bhattarai, Y., & Kashyap, P. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00049.2016 · Cited by 20
Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
Arsenijevic, T., Nicolle, R., Bouchart, C., D’Haene, N., Demetter, P., Puleo, F., & Laethem, J. V. (2021) · Cancers · doi:10.3390/cancers13061231 · Cited by 19
Mempin, M., Hu, H., Vickery, K., Kadin, M. E., Prince, H. M., KOUTTAB, N. M., Morgan, J. W., Adams, W. P., & Deva, A. K. (2021) · Cancers · doi:10.3390/cancers13215298 · Cited by 19
Reis, S. K., Socca, E. A. R., de Souza, B. R., Genaro, S. C., Durán, N., & Fávaro, W. J. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101747 · Cited by 20
Sasaki, T., Matsumoto, Y., Murakami, K., Endo, S., Toyozumi, T., Otsuka, R., Kinoshita, K., Hu, J. H., Iida, S., Morishita, H., et al. (2023) · Esophagus · doi:10.1007/s10388-023-01004-0 · Cited by 19
Modulating gut microbiota using nanotechnology to increase anticancer efficacy of the treatments
Jalil, A. T., Thabit, S. N., Hanan, Z. K., Alasheqi, M. Q., Al-Azzawi, A. K. J., Zabibah, R. S., & Fadhil, A. A. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00168-z · Cited by 19
Exploring the human microbiome – A step forward for precision medicine in breast cancer
Jotshi, A., Sukla, K. K., Haque, M. M., Bose, C., Varma, B., Koppiker, C. B., Joshi, S., & Mishra, R. (2023) · Cancer Reports · doi:10.1002/cnr2.1877 · Cited by 20
Garg, S., Sharma, N., Bharmjeet, & Das, A. (2023) · Cancer Reports · doi:10.1002/cnr2.1892 · Cited by 20
Ye, H., Ghosh, T. S., Hueston, C. M., Vlčková, K., Golubeva, A. V., Hyland, N. P., & O’Toole, P. W. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2282796 · Cited by 19
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
Karaman, İ., Pathak, A., Bayık, D., & Watson, D. C. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i1.657 · Cited by 20
Sun, L., Wang, X., Zhou, H., Li, R., Meng, M., Roviello, G., Oh, B., Feng, L., Yu, Z., & Wang, J. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1201 · Cited by 20
Integrating tumor genomics into studies of the microbiome in colorectal cancer
Burns, M. B., & Blekhman, R. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1549421 · Cited by 19
Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
Yan, C., Tu, X., Wu, W., Tong, Z., Liu, L., Zheng, Y., Jiang, W., Zhao, P., Fang, W. J., & Zhang, H. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i11.1253 · Cited by 19
When human cells meet bacteria: precision medicine for cancers using the microbiota.
Zhang, H., & Sun, L. (2018) · Europe PMC (PubMed Central) · Cited by 20
Catania, F., Baedke, J., Fábregas‐Tejeda, A., Delgado, A. N., Vitali, V., & Long, L. A. N. (2021) · BioEssays · doi:10.1002/bies.202100049 · Cited by 19
Manfredi, C., Calace, F. P., Fusco, F., Quattrone, C., Giordano, D. R., Crocetto, F., Creta, M., SIO, M. D., & Arcaniolo, D. (2021) · World Journal of Urology · doi:10.1007/s00345-021-03773-8 · Cited by 19
The Use of Gut Microbial Modulation Strategies as Interventional Strategies for Ageing
Siddiqui, R., Mungroo, M. R., Alharbi, A. M., Alfahemi, H. H., & Khan, N. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091869 · Cited by 19
Shi, Y., Luo, J., Narbad, A., & Chen, Q. (2023) · Microorganisms · doi:10.3390/microorganisms11010179 · Cited by 21
Mohamed, A. S., Bhuju, R., Martinez, E., Basta, M., Deyab, A., Mansour, C., Tejada, D., Deshpande, V., Elias, S., & Nagesh, V. K. (2025) · Cancers · doi:10.3390/cancers17172795 · Cited by 18
Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
Elbehi, M. A., I, A. R., Ekine-Afolabi, B. A., & Cash, E. D. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104977 · Cited by 19
Immuno-oncology-microbiome axis of gastrointestinal malignancy
Lin, Q., Guan, S.-W., & Yu, H. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.757 · Cited by 20
Diwan, P., Nirwan, M., Bahuguna, M., Kumari, S. P., Wahlang, J., & Gupta, R. K. (2023) · Pathogens · doi:10.3390/pathogens12080996 · Cited by 20
Zhao, H., Zhang, L., Du, D., Mai, L., Liu, Y., Morigen, M., & Fan, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113195 · Cited by 23
Dias, A., de Nonohay, U., & Blessmann, G. (2012) · Arquivos rio-grandenses de medicina · Cited by 18
Wang, Q., Li, L., & Xu, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-24315-0 · Cited by 18
Interaction of bacteria and stem cells in health and disease
O’Rourke, F., & Kempf, V. A. J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz003 · Cited by 18
Metadata
- Authors
- Schwabe, R. F., & Jobin, C.
- Affiliations
- Columbia University (US)
- University of Florida Health (US)
- Corresponding author
- Schwabe, Robert F.
- Jobin, Christian
- Venue
- Nature Reviews Cancer
- Published
- 2013-10-17
- Volume
- 13
- Issue
- 11
- Pages
- 800-812
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3986062
- OpenAlex
- W2016853666
- Cited by
- 1,689
- References
- 205
- Citations by year
- 2026: 87 · 2025: 123 · 2024: 135 · 2023: 141 · 2022: 207 · 2021: 214 · 2020: 150 · 2019: 138 · 2018: 146 · 2017: 103 · 2016: 110 · 2015: 77 · 2014: 54
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54CA163111)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK047700, R01DK073338, R01DK076920)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, carcinogenesis, dysbiosis, host-microbe symbiosis, bacterial sensing, immune response, genotoxicity, host metabolism, cancer prevention, microbiome-targeted therapy
- MeSH terms
- Animals, Bacteria, Diet, Humans, Immune System, Mutagens, Neoplasms, Symbiosis, Gene Expression Regulation, Bacterial, Gene Expression Regulation, Neoplastic, Virulence Factors, Mice, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review